Curis, Inc. (CRIS) - NASDAQ
From other sites
Company Description
Curis, Inc. is a biotechnology company, which is to develop and commercialize innovative drug candidates for the treatment of human cancers. Its pipeline includes two clinical stage drug candidates: CUDC-907, a dual HDAC and PI3K inhibitor, and CUDC-427, a small molecule IAP antagonist. The... More
Sector: Healthcare
Industry: Biotechnology
Country: United States